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When the first experimental systems showing a biological
effect of extracellular matrix on cells were presented about 20
years ago, for example, the stimulation of myoblast differenti-
ation in culture by collagen [1], there was apparently no need
for an exogenous matrix (ECM) control of cell differentiation—
everything seemed to be determined by the genes, regulating all
cellular events. For many years there was general scepticism
about a specific role for the ECM in cell development and
differentiation. How could such large macromolecules, many of
which hadn't even been structurally characterized, exert spe-
cific effects on cells, and how would cells be able to recognize
matrix molecules?
Several decades of tedious biochemical and molecular bio-
logical analysis of the extracellular matrix led to the discovery
of numerous new tissue-specific matrix molecules of isoforms
and splice variants, and of specific cellular receptors for these
molecules, to make an acceptable hypothesis: that ECM com-
ponents may affect and regulate cellular events in a specific and
reproducible manner, similar to growth factors, cytokines or
hormones. Today, experimental evidence from cell and organ
culture models is overwhelming that almost all cellular events
occurring during embryonic development and organogenesis,
during tissue remodelling, wound healing or metastasis are in
some way influenced by individual components of the ECM,
and that these responses are specific," Some cells form focal
contacts and stress fibers on fibronectin, but not on laminin.
Some epithelial cells, like MDCK cells or endothelial cells,
polarize and form duct-like structures within a collagen gel [2,
3], while lens epithelial cells depolarize in such a gel [4]. Nerve
cells send out neurites on laminin, but not on fibronectin or
collagen. Recent studies with antibodies against matrix mole-
cules and their receptors have shown that such specific cell-
matrix interactions not only explain in vitro phenomena, but do
play an essential role in embryonic development and tissue
remodelling in situ [5, 6]. The list of cellular responses to
extracellular matrix, including adhesion and spreading, changes
in cytoskeleton and cell shape, induction of polarity and differ-
entiation, stimulation of proliferation and migration, and also
such phenomena as induction of proteases, platelet aggregation,
collagen gel contraction or reduction of metastatic activity is
growing. A number of comprehensive reviews cover the liter-
ature on cellular responses to extracellular matrix until 1985
[7—9]. The biological effects of fibronectin, probably the most
intensely investigated matrix molecule, are completely summa-
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rized in two books [10, Il]. Numerous reviews exist on the
biological role of laminin [12—15], tenascin [16], on the role of
the ECM in development [171 and on leucocyte activation and
differentiation [18, 19]. As it is impossible to give a complete
overview of the literature on this topic within the limits of this
short review, a few examples will be presented to explain the
complexity of cellular responses to ECM molecules will be used
all the way from the extracellular structure through the recep-
tor, and inside the cell. To do this, it is necessary to briefly
outline the structural principles of the major ECM molecules,
and its cellular receptors.
Biologically active structures of extracellular matrix molecules
The biological activities of extracellular matrices reside both
in their single components, and in their structural integrity.
Most extracellular matrices contain a fibrous backbone of
collagens or other fiber-forming proteins such as elastin, fibrillin
or fibronectin, into which proteoglycans, glycoproteins or gly-
cosaminoglycans such as hyaluronic acid are incorporated.
Some of the adhesive matrix components are as follows.
Fibronectin
Fibronectin is a large glycoprotein consisting of two disulfide-
linked subunits (A and B chains) of molecular weight 200,000
that occur in several splice variants [10, 11, 20, 21]. A cell
surface protein of most mesenchymal cells, and a soluble
protein in plasma, it is involved in a broad range of biological
activities, It has been shown to promote adhesion and spreading
of mesenchymal and epithelial cells, to stimulate proliferation
and migration of embryonic and tumor cells, and to control cell
differentiation, cell shape and cytoskeletal organization.
Biochemical and molecular biological characterization of
fibronectin and its gene (there is only one gene for both A and
B chains) revealed a multidomain structure which is typical for
most large extracellular matrix proteins, for example laminin,
tenascin, chondroitin sulfate proteoglycan (aggrecan), von
Willebrand factor, etc. By limited proteolysis fibronectin can be
cleaved into separate, functionally independent entities that are
aligned in a linear fashion: a collagen (gelatin) binding domain,
two heparin-binding domains, DNA-, proteoglycan- and fibrin-
binding domains, and at least two cell-binding domains [10, 21].
The interaction sites for other macromolecules are important
for the matrix assembly [22]. Sequence analysis of fibronectin
revealed that both chains are identical (with the exception of
splice variations; such as, a short III CS domain lost in one
chain in plasma fibronectin) and consist of three types of
structural repeats (homologies): 15 type I repeats (each 45
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amino acid residues long), two type II repeats (60 amino acid)
and 15 to 16 type III repeats. Homologous structural domains
keep appearing in other matrix molecules, for example, in
tenascin [231 or undulin [241.
The possibility of isolating small cell binding fragments of
fibronectin by limited proteolysis and further narrowing down
of the cell binding sequence to Arg-Gly-Asp (RGD) as the
smallest cell-binding sequence of fibronectin and other matrix
proteins [25] led to the discovery of the fibronectin receptor.
This receptor belongs to the still growing family of integrins, a
class of heterodimeric transmembrane proteins of different
specificity and affinity to various matrix molecules and other
cell surface proteins [reviewed in 26—28]. Some 13 a-chains and
an eight /3-chains have been described so far that assemble into
various combinations of integrin molecules. Not all integrins
recognize an RGD-motif in their matrix ligand. Data about
specificity and affinity of the various integrins are still contro-
versial as they are mostly deduced from different in vitro
assays, and depend on the type of divalent cation present
(Ca, Mg or Mn) [29], the type of phospholipids, and
probably also on cellular origin and the type of glycosylation.
Only few integrins are specific only to one ligand, like the aJ31
for fibronectin [30], or a6/31 and a7/31 for laminin [31, 32].
Others, such as a1/31 or a3/31, bind to multiple ligands [33].
Curiously, a2f31 integrin from endothelial cells binds both
collagen and laminin [34], while a2J31 from platelet membranes
binds only to collagen [35]. Many integrins were identified by
monoclonal antibodies that were selected for their ability to
inhibit cell adhesion to matrix molecules, but we will see that
they are also involved in a number of other cellular activities
induced by ECM.
f3 integrins have been shown to bind to actin filaments with
their cytoplasmic domain, an interaction mediated by a-actinin,
vinculin and talin [36, 37], and are thus probably involved in the
induction of focal contacts by fibronectin. How other trans-
membrane signals of the ECM, such as those leading to
proliferation or onset of gene expression, are mediated by
integrins is a matter of burning interest; perhaps the tyrosine
kinase sequence target found in the cytoplasmic domain of
some /3-chains is the key to a transmembrane signalling mech-
anism.
Laminin
Laminin as the major adhesive glycoprotein of basement
membranes not only serves as adhesive substrate for various
epithelial and mesenchymal cells, but is also able to induce and
control a number of biological activities, For example, it
stimulates neurite outgrowth, enhances proliferation and motil-
ity of tumor cells and skeletal myoblasts, induces polarization
and differentiation of mammary epithelial cells, melanoma cells,
endothelial cells and others [reviewed in 12, 14, 15]. It was
originally found as a large glycoprotein in the culture medium of
a murine embryonal carcinoma cell line [38], but only the
discovery of the murine basement membrane EHS tumor
(Engelbreth Holni Swarm-tumor) permitted the isolation and
purification of laminin in quantities sufficient to allow extensive
functional and structural studies [39]. After rotary shadowing
EHS laminin appears in the electron microscope as a cross-
shaped molecule with one long and three short arms, carrying
globular domains within the short arms and at the end of all four
arms. The native molecule of Mr 800 K separates into an
A-chain of apparent Mr 400 K, and two B-chains of 200 K and
220 K on reducing SDS gels. The complete primary structure of
all three chains was established by protein and cDNA sequenc-
ing [reviewed in 13, 39, 40]. By a combination of electron
microscopical, physico-chemical and sequence data it was
concluded that the three chains assemble with their heptad
repeat a-helical domains to a triple-stranded coiled-coil struc-
ture, corresponding to the long arm of the molecule [41]. The
long arm is terminated by a large globular domain consisting of
five homologous foldings of the A-chain [42, 43]. At the center
of the cross the three chains separate into single strands,
forming the short arms with alternating globular and cysteine-
rich rod-like domains. Similar to fibronectin, laminin is a
multifunctional protein. By limited proteolysis and binding
assays with the fragments specific functions can be assigned to
various domains. Multiple interactions with other components
of the basal laminina such as nidogen (entactin) [44], heparan
sulfate proteoglycan and type IV collagen on one side [40] and
with cells through cell receptors on the other side, let laminin
appear as a key molecule in mediating cell interactions with
basement membranes. The binding site for nidogen (entactin), a
dumbell shaped molecule which was also called laminin C-chain
[44, 45] is located in the short arm of the B2-chain (R. Timpl, R.
Nischt, manuscript in preparation). Heparin binding sites are
located in the terminal globule of the long arm [46], and type IV
binding was observed at the terminal globules of the short arms
[47, 48]. By limited cleavage with elastase, chymotrypsin,
pepsin or cathepsin, laminin can be cleaved into biologically
active fragments [46, 49]. A tumor cell binding site was identi-
fied on the center part of the cross, that is, in the Cl, P1 or El
fragments obtained by cleavage with chymotrypsin, pepsin or
elastase, respectively. Many cells attach to the El fragment in
an RGDS-independent manner [Note added in proof, A]; this
site may be "cryptic" and appears not to be active in the native
laminin molecule [51]. There is evidence from several labora-
tories that a short sequence in the B I-chain consisting of five
amino acid residues (YIGSR) is also responsible for cell inter-
actions [52]. The cell receptor recognizing this site may be the
67 kD laminin-binding protein [52—54]. Other cells bind to the
El fragment in an RGDS dependent manner, with a different
binding site and an a1$1 integrin receptor being involved [55].
At least one, and perhaps three high-affinity cell-binding sites
are located at the end of the long arm of laminin, which can be
prepared by elastase digestion (E8 fragment). Not only adhe-
sion of a number of cells (such as, HT 1080, Rugli, myoblasts,
melanoma cells), but also neurite outgrowth and myoblast
migration are stimulated by this site. A 19-mer peptide called
PA-22-2 from the B 1 chain sequence of this region, and within
that peptide the sequence IKVAV in particular, has been shown
to promote adhesion, migration, differentiation and neurite
outgrowth [56]. Other data, however, show that for adhesion of
some cells to E8 all three chains in a native confirmation are
required [50, 57], suggesting several binding sites within this
region.
Adhesion of platelets, H 1080 and B16 melanoma cells to the
E8 fragment is specifically inhibited by the monoclonal anti-
body GOH3 directed against the a6f31 integrin chain [32]. Other
cells such as Rugli cells, myoblasts or human MeWo melanoma
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cells utilize the related a7/31 integrin chain [31, 58] instead of the
s6-chain.
In embryonic development, laminin is the earliest matrix
macromolecule found so far; it appears as a B1B2 complex
without A-chains, however [591. Similarly, in kidney develop-
ment, only B-chains were seen in the differentiated mesen-
chyme, while the A-chain appeared only during tubulogenesis
[60]. In other tissues such as muscle, placenta and Schwann
cells, a laminin isoform with another A-chain, the so-called
merosin (M) chain, was found [61], Other isoforms of laminin
include the S-laminin (a molecule containing an S-chain instead
of a B 1-chain) in synapses and glomerular basement membranes
[62, 63], laminin from mouse heart muscle [64], as well as
laminins from sea urchins, leech, Drosophila, and human pla-
centa.
Collagens
Fourteen collagen types have been described so far (more are
coming!), but cellular responses have been described only for
types Ito VII. Collagen types I, II, III, V and XI belong to the
family of fibril-forming collagens [reviewed in 65, 661. They
have little in common with nonfibril-forming collagens that form
networks (such as, type IV collagen [67], or type X collagen
[68]), microfibrils (type VI collagen [69]), or yet unknown
structures, except the triple helical structures with glycin in
every third position and a high content of proline and hydroxy-
proline. Also, the gene structure of the fibril forming collagen
which is characterized by a high exon number (around 45 to 50
exons) and a typical exon size of 54 or 45 nucleotides is
basically different from that of other collagens, suggesting
separate evolutionary traits [reviewed in 65, 70—72].
For cell biological studies type I collagen has been the most
widely used collagen. Cells have three different ways of inter-
acting with type I or other fibril-forming collagens: 1) a confor-
mation independent way, with cells recognizing both triple
helical and denatured collagen (such as, hepatocyte adhesion to
collagen; [73]; 2) a triple-helix-dependent mechanism [60], and
3) a type of recognition requiring fibrillar structures (such as,
platelet aggregation [7]). The latter type of interaction probably
plays a role in the most dramatic cellular reactions observed in
hydrated collagen lattices (gels), such as the epithelial mesen-
chymal transformations of lens epithelium [4], capillary duct
formation of endothelial or MDCK cells [2, 3, 75], or polariza-
tion and differentiation of mammary epithelial cells [76, 77].
Thus, in contrast to fibronectin or laminin, which seem to
bear only few, well-defined cell binding sites, collagen has
multiple cellular interaction sites along its triple helix and the
fibril. Besides such "repetitive" sites, however, a preferential
c2 integrin binding site has been identified in the CB3 fragment
of the al(I) collagen chain [781. Also in type IV collagen, a
dominant al integrin binding site is located in the CNBr-
fragment CB3 [79]. In type VI collagen, a microfibrillar collagen
with strong cell adhesive character [80], a high number of RGD
sequences have been identified, explaining the strong adhesive
character of the a2(VI) and a3(VI) chains, while RGD-motifs in
type I collagen seem not to be active in cell adhesion [811. The
mechanism of cell-collagen interaction has been unclear for a
long time. With the discovery of fibronectin as a collagen-
(gelatin) binding serum glycoprotein, a mechanism was propa-
gated in which fibronectin mediates cell adhesion to collagen
[12, 82]. Later experimental evidence has shown that cell-
collagen interactions also occur in the absence of serum [83]. A
number of collagen binding proteins were subsequently isolated
from cell membranes, such as 68 kD proteins from platelets [84]
or corneal epithelial cells, or the 34 kD collagen-binding protein
anchorin CII, a component of chondrocyte and bone cell
membranes [851. The role of these proteins in cell collagen
interaction, however, remained unclear. Anchorin CII has
recently been identified as a major protein component of matrix
vesicles [861, and probably plays a role in collagen-nucleated
cartilage and bone matrix calcification.
Cellular interactions with collagen and fibronectin may in
some cases also be mediated by a membrane-intercalated
heparan sulfate proteoglycan. One of these molecules, called
syndecan [87], has been shown to bind to fibronectin and native
collagens I, II and III through the heparan sulfate side chains.
Recent overwhelming evidence is that the major collagen
receptors also belong to the family of integrins. In particular
with antibody inhibition experiments, but also with purified
integrins reconstituted into liposomes, three integrins of the /31
class, alf3l, a2/3l and a3/3l, were shown to be involved in
collagen-cell interactions in vitro [33, 35; for overviews see 18,
26, 28].
Cellular responses to extracellular matrix
When cells are brought in contact with macromolecules of the
ECM in vitro they respond in a variety of ways, sometimes
highly selective and rapid, in other cases slowly and unspecif-
ically. Although there may be general reservations against such
in vitro studies, evidence is strong that cellular responses to
ECM seen in cell or organ culture, such as cell elongation,
polarization, migration or differentiation, reflect comparable
situations in a developing embryo or in a metastasizing tumor.
At the moment, cell and organ culture systems seem to be the
best to elucidate the biological activity of individual matrix
components or their receptors, until the techniques of muta-
genizing or inactivating matrix molecules selectively in an
organism, such as in a transgenic mouse, become more easy to
apply to such problems. The following will briefly summarize
recent findings on cellular responses to ECM. The separation
into adhesion, changes in cell shape, migration, proliferation,
differentiation and changes in gene expression seem artificial
and are more for technical reasons. Actually, the contact of a
cell to ECM components, or the loss of contact to them,
induces a chain of events that are not autonomous. For exam-
ple, a mouse mammary epithelial cell first attaches to a collagen
gel, then polarizes and turns on expression of the casein gene
and other milk proteins [77]; all these events represent aspects
of differentiation. When a chondrocyte is plated on fibronectin,
the formation of focal contacts and stress fibers is induced, the
cell flattens and changes its cell shape and finally its gene
expression pattern. The whole reaction is reversible when cells
are removed from the fibronectin and are embedded into
agarose [88].
Adhesion
Of all cell-matrix interactions studied, experiments on cell
adhesion or attachment are probably the most debated issues.
Cell adhesion rates to matrix-coated culture dishes, not consid-
ering cellular responses such as spreading or elongation, have
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Table 1. Cell adhesion to ECM macromolecules (selection)
Cell type Matrix Integrin Reference
Fibroblasts FN a5131 [30] Pytela et al, 1985
Wi 38 hum. fib. Cot. I, III a2I31
a3/31
[331 Wayner et al, 1988
[33] Wayner et at, 1988
Fibrosarcoma LN E8 aj31 Note added in proof, B
HT 1080
Myoblasts (murine)
Col. 1, IV
LN
a1f3, a2131
a7f3
[791 Vandenberg et at, 1991
[581 von der Mark et al, 1991
Myoblasts FN a5f31 [58] von der Mark et at, 1991
Smooth muscle myoblast Cot. I, LI, III, IV a1f31 [89] Belkin et at, 1990
Epithelial cells LN a6/31 [49] Aumailley et at, 1990
Human. mammary ep. c. LN 13 [90] Sonnenberg et al, 1990
HBL-100 kalinin a6/34 [91] Kajiji et at, 1989
Endothelial cells LN cssl3i,crvl3s [31] Kramer et at, 1990
vascular
Hepatocytes Col.
LN
a/31, a2f31
a1/31
[92] Gutlberg et al, 1990
[93] Forsberg et at, 1990
Glioblastoma LN (human) cE3f31 [94] Gehlsen et a!, 1989
rat, Rugli LN E8 (EHS) a7f31 [58] von der Mark et a!, 1991
Kidney cell line 293 VN cxf31 [95] Bodary & McLean, 1990
Keratinocytes FN a5131 [96] Adams & Watt, 1990
Carcinoma:
Melanoma, B16 (mouse) LN(E8) aj31 [97] Ramos et a!, 1989
MeWo melanoma (human) LN(E8) a7/31 [31] Kramer et al, 1989
MeWo melanoma Col. I, IV aj3, a2f31 [97] Ramos et at, 1990
MeWo melanoma VN a/33 [98] Cheresh, 1987
Lox melanoma LN a2/3 [99] Elices & Hemler, 1989
Leucocytes FN
LN
Cot.
a431
aj31
a1,a2,a3131
[100] Hemter et al, 1987
[101] Shimizu et al, 1990
[18] Hemler, 1990
Platelets Col.
FN, VN, FB
LN
IaIIa(=ECMR II)
(= VLA-2)
IIbIIIa(crllb/33)
IcIla
a6f34
[1021 Kunicki et al, 1988
[35] Santoro, 1986
[1031 Pytela et at, 1986
[104] Piotrowic et at, 1988
[32] Sonnenberg et at, 1989
Abbreviations are: FN, fibronectin; LN, laminin; Cot, collagen; VN, vitronectin; FB, fibrinogen.
been extensively determined to describe affinities of cells to
matrix molecules and to identify receptors and matrix epitopes
involved. But the variety of criteria and techniques to measure
cell attachment and to discriminate attached and non-attached
cells is probably as large and heterogeneous as are the labora-
tories describing such assays and the cell types used for them.
In general, reproducible results are obtained when assays are
done with stringent washing conditions, considering time- or
dose-dependence of adhesion, or when counting only spread
cells.
Most cells bind to more than one matrix molecule (Table 1);
for example, most fibroblasts bind to fibronectin, collagen,
vitronectin, and many also to laminin, although the latter was
originally considered to allow only adhesion of epithelial cells.
Vice versa, many epithelial cells also adhere to fibronectin or
interstitial (such as type I) collagen, although they may not
"see" these molecules in situ.
Many cells utilize different integrins to attach to different
macromolecules; often integrins are induced on the cell surface
after exposure of a cell to a matrix molecule [28]. On the other
hand, different cells may use different integrins to bind to the
same molecule. For example, mammary epithelial cells or Bl6
melanoma cells use aj31 to bind to the E8 binding site in
laminin, whereas Rugli cells or myoblasts use a7131 to bind to
the same fragment [58]. The same cell may simultaneously use
different integrins to interact with the same matrix component.
For example, fibroblasts initially adhere to fibronectin in an
RGD dependent fashion using the a5/31 integrin [30], but spread-
ing on fibronectin also involves the heparan sulfate binding
region of fibronectin [105] (the receptor is yet unknown).
Leucocyte adhesion to fibronectin, however, involves the IIICS
splice site and cx4f31 integrin [181 (Table 1).
Cell spreading, formation of focal contacts and stress fibers
One possible response of a cell to an extracellular matrix
protein is that it decides to spread, settle down and develop
focal contacts or adhesion plaques. These are v-shaped mem-
brane specializations that are connected to the matrix substrate
within 10 to 20 nm through integrins, and to the actin stress
fibers through vinculin, talin and a-actinin [37, 106, 107]. The
key element of the transmembrane connection between exo-
skeleton and cytoskeleton is the cytoplasmic domain of the /3
integrin chain that has been shown to bind talin [107] and
a-actinin [37]. Whether a cell decides to form focal contacts or
to migrate depends on the nature of the substrate. For example,
skeletal myoblasts rapidly move on laminin, but spread and
develop focal contacts on fibronectin [1081. Dejana et al [109]
have shown that the organization of RGD integrins a5/31 (fi-
bronectin receptor) and av/33 (vitronectin receptor) [103] into
focal contacts is induced only by the corresponding matrix
protein. The existence of such focal contacts is not permanent,
however, but is regulated by the integrin-mediated contact to
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the matrix. For example, addition of GRGDS-peptide to focal
contacts causes dissolution of a-actinin and vinculin from the
focal contact sites, indicating an impact on the conformation of
the integrin receptor (cf31) [36).
Migration, motility, haptotaxis, chemotaxis
Cells migrate long distances along defined routes and arrive at
distinct target sites in normal embryonic development, during
wound healing and tissue regeneration. Why cells move, how
they know where to migrate, and where they settle down have
been fascinating, but unsolved problems in the past decades.
With the discovery of specific cell-cell adhesion molecules
(reviewed in 17] and specific cell-matrix recognition mecha-
nisms, we begin to understand the precise control of cellular
migration in embryonic development as well as the loss of the
control in metastasizing tumors. Cell migration in the embryo
can be followed using fluorescent tags or other markers, such as
the nucleolus of quail cells implanted into chick embryos [1101.
Important information on the control of cell migration by
extracellular matrix also has been gained from the analysis of
the ECM composition along migration pathways in the embryo
and from attempts to block migration in situ with antibodies to
matrix proteins or their receptors. For example, injection of
antibodies against the l subunit of chicken integrins (CSAT;
58) blocked the migration of neural crest cells in the cephalic
region of a chick embryo [5, 111], and a similar result was
obtained with the RGDS-peptide [61. In vitro, neural crest (NC)
cells migrate on dishes coated with either fibronectin, laminin,
tenascin or heparan sulfate proteoglycan but less well on
collagen [112; reviewed in 113]. These molecules are also found
in the various migratory routes of NC cells in the embryo. How
the differential recognition of these components and of other
cells finally determines the route and fate of neural crest cells in
situ will require further investigations.
There are numerous other migratory cells in the embryo such
as melanocytes, cytotrophoblasts, primordial germ cells and
skeletal myoblasts that have been shown to respond to extra-
cellular matrix. The skeletal myoblasts of the extremities im-
migrate during the early phase of limb development from the
myotomal part of the adjacent somites [114]. Also, during
muscle repair satellite cells can immigrate along the muscle
basement membrane to sites of muscle injury to differentiate
and fuse to myotubes [115]. Time lapse photography of cell
migration in the translucent Zebra fish embryo has shown that
myoblast move towards the tail [1161. In the chick this cell
movement can be blocked by injecting anti-/31 integrin antibod-
ies, indicating that collagen, fibroriectin or laminin is involved
[1171. In vitro embryonic myoblasts from mouse skeletal mus-
cle as well as myoblast cell lines migrate about 10 times as fast
on tracks of laminin as on fibronectin [108, 118]. In contrast,
chick myoblasts migrate on fibronectin substrates [119]. Murine
myoblasts only recognize the E8 fragment of laminin for migra-
tion, not the E1-4-fragment. By affinity chromatography and
immunoprecipitation the a.,131 complex has been identified as
the major laminin-E8-binding integrin of murine myoblasts [58].
The nature of the transmembrane signal elicited by laminin that
enhances myoblast motility so dramatically remains to be
found.
Time lapse videomicroscopy of migrating myoblasts has
revealed that the observed cell migration into tracks is due to
increased, non-directed cell motility, which allows cells to fill
empty space, but is not due to directed migration such as
chemotaxis. Chemotactic migration of fibroblasts in a Boyden
chamber against a gradient of fibronectin and collagen frag-
ments has been noted [120], whereas migration of cells on
matrix-coated surfaces is referred to as haptotaxis which is not
directed.
Outgrowth of cell processes and neurites
Several cell types including Schwann cells [121] and myo-
blasts [118] develop cell processes when plated on laminin;
fibroblasts become elongated and spindle shaped when grown in
a collagen gel [1221. The most spectacular and specific effect of
laminin, however, is the induction of neurite outgrowth in
neuronal cells [123—125]. As in myoblasts, the activity was
located in the E8 fragment.
Proliferation
Most normal tissue cells divide only when anchored to a solid
substrate; only cells of the hematopoietic system, chondrocytes
and tumor cells divide in an anchorage-independent manner.
Thus it is easy to demonstrate increased cell proliferation by
offering cells more and better substrates for adhesion, but the
question remains whether such effects are only in vitro phe-
nomena. Another problem is that the presence of low amounts
of growth factors, such as FGF, which bind strongly to heparan
sulfate, a constituent of basement membranes and other matri-
ces, is difficult to exclude, particularly in cultures that are
exposed to serum [126].
The most striking example is probably the stimulation of
3T3-fibroblast proliferation by an EGF-like fragment of the
laminin B I-chain [127]. The mechanism of this stimulation,
which does not involve the EGF receptor, is unclear.
Polarization and epithelial-mesenchymal transformation
A number of epithelial cells depolarize and dedifferentiate to
mesenchymal cells when cultured in tissue culture dishes.
However, when plated onto reconstituted collagen gels or
basement membrane matrices (matrigel), cells reorganize their
epitheloid, polarized shape, develop gap junctions and desmo-
somes, and often express differentiation genes, For example,
mammary epithelial cells polarize on collagen gels [77, 128] and
on matrigels [761, and increase the synthesis of milk proteins.
Thyroid epithelium and pancreatic endocrine cells reorganize
into islet-like organoids in a collagen matrix [75]. Lens epithelial
cells, however, (a pseudoepithelial cell containing vimentin
instead of keratin) depolarize in a collagen gel and change their
gene expression from type IV to type I collagen synthesis [4].
The basal laminia (BL) of epithelial cells is essential for the
maintenance of the polarity and function of epithelium. When
the BL is destroyed, cells depolarize, stop synthesizing corneal
matrix proteins and dissolve their basal cortex [129]. These
events are reversible after culturing such epithelia on collagen
or laminin.
Collagen gels are also able to induce capillary endothelial
cells to form duct-like structures and to branch [2]. This event
can be enhanced by PDGF, while the tube formation of MDCK
(kidney) cells in a collagen gel can be induced by FGF [3].
Fibroblasts respond to culture within a collagen gel by
contracting the gel to about one-twentieth of its original size
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[130]. During this contraction the collagen synthesis decreases
dramatically, reaching levels as low as in situ [1311. The
interaction of fibroblasts with the collagen fibrils is mediated by
a2f31 integrin; anti-f31 and anti-a2 antibodies can inhibit gel
contraction considerably [61, 92].
Other responses
The clinical importance of the extracellular matrix in cell
behavior has become most evident in the analysis of mecha-
nisms of tumor invasion and metastasis. Invasive carcinoma
cells encounter extracellular matrix at several sites of their
metastatic tumor progression. They show specific responses to
ECM molecules, beginning with the production of proteases
which are induced by the matrix [132], during penetration of
basement membranes and other types of ECM of the tumor
capsule and blood vessels, during migration, adhesion, and
proliferation in distant tissues [reviewed in 133]. The induction
of proteases in normal and tumor cells is also mediated by
integrins [132].
Similar interactions with the extracellular matrix were de-
scribed in the process of angiogenesis [133]. Other important
systems of cell-matrix interactions that are only mentioned here
briefly are the collagen-induced platelet aggregation [35], or the
VLA-mediated adhesion and differentiation of leucocytes on
ECM [18]. In all those events integrins play a central role, but
other matrix receptors such as syndecan [87], or the 68 kD
laminin binding protein [53, 54] may also be involved. Future
research will show how the signals elicited by the ECM
molecules are translated into intracellular signals, leading to
alterations in cell shape, motility, cytoskeletal architecture or
gene expression.
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